PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin
Public ClinicalTrials.gov record NCT01227629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Dose Exploration in Patients With Atrial Fibrillation
Study identification
- NCT ID
- NCT01227629
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 502 participants
Conditions and interventions
Conditions
Interventions
- dabigatran with ASA Drug
- warfarin Drug
- dabigatran without ASA Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2003
- Primary completion
- Oct 31, 2004
- Completion
- Not listed
- Last update posted
- May 4, 2014
Started 2003
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1160.20.10010 | Fayetteville | Arkansas | — | — |
| 1160.20.10003 La Mesa Cardiac | La Mesa | California | — | — |
| 1160.20.10006 The Ford Research Institute, PA | Pensacola | Florida | — | — |
| 1160.20.10004 | Port Charlotte | Florida | — | — |
| 1160.20.10002 | St. Petersburg | Florida | — | — |
| 1160.20.10015 | Baltimore | Maryland | — | — |
| 1160.20.10008 | Westminister | Maryland | — | — |
| 1160.20.10012 | Pittsfield | Massachusetts | — | — |
| 1160.20.10007 | Troy | Michigan | — | — |
| 1160.20.10014 | Hawthorne | New York | — | — |
| 1160.20.10013 | New Hyde Park | New York | — | — |
| 1160.20.10009 | North Durham | North Carolina | — | — |
| 1160.20.10001 | Philadelphia | Pennsylvania | — | — |
| 1160.20.10005 | Germantown | Tennessee | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01227629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2014 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01227629 live on ClinicalTrials.gov.